Eribulin Viatris

Eribulin Viatris is a medication used for certain types of cancer treatment. This intravenous drug is manufactured by Viatris Limited and is available in the EU market.

Eribulin Viatris is primarily used in the treatment of advanced breast cancer. It is often considered when other treatments have not been effective. The drug works by interfering with the growth and spread of cancer cells, making it a crucial option for managing specific types of cancer.

Common effects of Eribulin Viatris may include fatigue, nausea, and hair loss. Some patients might experience peripheral neuropathy, which can cause tingling or numbness in the hands and feet. These effects can vary from person to person and should be discussed with a healthcare provider.

Eribulin Viatris should be handled with care and administered by healthcare professionals. It is important to follow all safety guidelines when using this medication. Patients should be monitored for any signs of adverse reactions and should report any unusual symptoms to their healthcare provider immediately.

Eribulin Viatris may interact with other medications, including those that affect the liver or bone marrow. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of the drug.